d the protocol was approved by the Catholic University of Korea Human Research Ethics Committee.

Reagents
Recombinant IL-17, IL-18, IL-15, monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein (MIP)-1α,